The YaSheng Group is planning three new products: a vaccine for foot-and-mouth-disease peptides, genetically engineered animal feed and a testing kit for use by governmental Customs agencies and the International livestock-trading industry.

Last August, YaSheng Group reported that its research and development team had mastered a gene-cloning process that allows the creation of fortified cells that combat foot-and-mouth disease. Scientists at the company also developed a cost-effective, easy-to-use, technique to test for FMD on either live or dead animals.

Design and development plans are in progress for the 100,000-square-foot facility. The headquarters and sales department will be located in Beijing, China. The facility will have a production area of 40,000 square feet, a 10,000-square-foot lab and an animal experimental testing area of 30,000 square feet.

YaSheng Group first plans to set up the manufacturing and high-yield production of a foot-and-mouth disease synthetic peptide vaccine. Research of foot-and-mouth synthetic peptide vaccine is still in the initial stages in China. With the production and application of this project, China may become free from the threat of Foot-and-Mouth disease. The company plans to export this vaccine around the world.

The second phase is to produce transgenic crops to use in feed to create an oral foot-and-mouth synthetic peptide vaccine. These transgenic crops include clover, livestock grass, lettuce, alfalfa and other animal feed additives.

The third is a kit for domestic and overseas trading and governmental customs uses in testing for foot-and-mouth disease. This testing kit will also be cost-effective and allow the process of testing to be simplified and applied in remote areas.

YaSheng has obtained two patents related to this project with a third in its final stages of approval.

You can learn more about the YaSheng Group at:

Source: YaSheng Group